| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $764.7M | -11.9% |
| Cost of Revenue | $456.2M | -10.3% |
| Gross Profit | $276.3M | -23.1% |
| R&D Expense | $81.7M | -12.0% |
| SG&A Expense | $128.9M | -12.0% |
| Operating Income | -$414.8M | -458.2% |
| Pre-tax Income | -$418.2M | -499.8% |
| Income Tax | $11.9M | +126.1% |
| Net Income | -$430.1M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $48.2M | -30.0% |
| Accounts Receivable | $134.7M | -8.1% |
| Inventory | $169.5M | +10.7% |
| Current Assets | $362.4M | -4.7% |
| Total Assets | $1.18B | -31.6% |
| Current Liabilities | $99.1M | -40.4% |
| Long-term Debt | $45.0M | -35.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Capital Expenditures | $32.1M | -34.0% |
| Investing Cash Flow | -$32.7M | +74.8% |
| Financing Cash Flow | -$73.2M | +44.3% |
| -386.0% |
| EPS (Basic) | -$4.69 | -387.7% |
| EPS (Diluted) | -$4.69 | -395.0% |
| Stockholders' Equity |
| $992.9M |
| -32.0% |